BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26340710)

  • 21. Insights into the substrate binding mechanism of SULT1A1 through molecular dynamics with excited normal modes simulations.
    Dudas B; Toth D; Perahia D; Nicot AB; Balog E; Miteva MA
    Sci Rep; 2021 Jun; 11(1):13129. PubMed ID: 34162941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testing the sulfotransferase molecular pore hypothesis.
    Cook I; Wang T; Almo SC; Kim J; Falany CN; Leyh TS
    J Biol Chem; 2013 Mar; 288(12):8619-8626. PubMed ID: 23362278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzymatic aspects of the phenol (aryl) sulfotransferases.
    Duffel MW; Marshal AD; McPhie P; Sharma V; Jakoby WB
    Drug Metab Rev; 2001; 33(3-4):369-95. PubMed ID: 11768773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variable sulfation of dietary polyphenols by recombinant human sulfotransferase (SULT) 1A1 genetic variants and SULT1E1.
    Ung D; Nagar S
    Drug Metab Dispos; 2007 May; 35(5):740-6. PubMed ID: 17293380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulfotransferase (SULT) 1A1 polymorphic variants *1, *2, and *3 are associated with altered enzymatic activity, cellular phenotype, and protein degradation.
    Nagar S; Walther S; Blanchard RL
    Mol Pharmacol; 2006 Jun; 69(6):2084-92. PubMed ID: 16517757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paradigms of sulfotransferase catalysis: the mechanism of SULT2A1.
    Wang T; Cook I; Falany CN; Leyh TS
    J Biol Chem; 2014 Sep; 289(38):26474-26480. PubMed ID: 25056952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of the substrate specificity of human sulfotransferases SULT1A1 and SULT1A3: site-directed mutagenesis and kinetic studies.
    Brix LA; Barnett AC; Duggleby RG; Leggett B; McManus ME
    Biochemistry; 1999 Aug; 38(32):10474-9. PubMed ID: 10441143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversible covalent inhibition of a phenol sulfotransferase by coenzyme A.
    Chodavarapu S; Hertema H; Huynh T; Odette J; Miller R; Fullerton A; Alkirwi J; Hartsfield D; Padmanabhan K; Woods C; Beckmann JD
    Arch Biochem Biophys; 2007 Jan; 457(2):197-204. PubMed ID: 17125724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural plasticity in the human cytosolic sulfotransferase dimer and its role in substrate selectivity and catalysis.
    Tibbs ZE; Rohn-Glowacki KJ; Crittenden F; Guidry AL; Falany CN
    Drug Metab Pharmacokinet; 2015 Feb; 30(1):3-20. PubMed ID: 25760527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of bovine phenol sulfotransferases: evidence of a major role for SULT1B1 in the liver.
    Choughule KV; Locuson CW; Coughtrie MW
    Xenobiotica; 2015; 45(6):495-502. PubMed ID: 25539458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polychlorobiphenylols are selective inhibitors of human phenol sulfotransferase 1A1 with 4-nitrophenol as a substrate.
    Wang LQ; Lehmler HJ; Robertson LW; James MO
    Chem Biol Interact; 2006 Feb; 159(3):235-46. PubMed ID: 16413005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single amino acid, glu146, governs the substrate specificity of a human dopamine sulfotransferase, SULT1A3.
    Dajani R; Hood AM; Coughtrie MW
    Mol Pharmacol; 1998 Dec; 54(6):942-8. PubMed ID: 9855620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structures of human sulfotransferases: insights into the mechanisms of action and substrate selectivity.
    Dong D; Ako R; Wu B
    Expert Opin Drug Metab Toxicol; 2012 Jun; 8(6):635-46. PubMed ID: 22512672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure, dynamics and selectivity in the sulfotransferase family.
    Leyh TS; Cook I; Wang T
    Drug Metab Rev; 2013 Nov; 45(4):423-30. PubMed ID: 24025091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural and Dynamic Characterizations Highlight the Deleterious Role of SULT1A1 R213H Polymorphism in Substrate Binding.
    Dash R; Ali MC; Dash N; Azad MAK; Hosen SMZ; Hannan MA; Moon IS
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potent inhibition of human cytosolic sulfotransferase 1A1 by 17α-ethinylestradiol is due to interactions with isoleucine 89 on loop 1.
    Rohn-Glowacki KJ; Falany CN
    Horm Mol Biol Clin Investig; 2014 Dec; 20(3):81-90. PubMed ID: 25418972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potent inhibition of human sulfotransferase 1A1 by 17α-ethinylestradiol: role of 3'-phosphoadenosine 5'-phosphosulfate binding and structural rearrangements in regulating inhibition and activity.
    Rohn KJ; Cook IT; Leyh TS; Kadlubar SA; Falany CN
    Drug Metab Dispos; 2012 Aug; 40(8):1588-95. PubMed ID: 22593037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of ligands on the thermal stability of sulfotransferases: a molecular dynamics simulation study.
    Zhang PP; Zhao L; Long SY; Tian P
    J Mol Model; 2015 Apr; 21(4):72. PubMed ID: 25750022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human cytosolic sulfotransferase SULT1A1.
    Hempel N; Gamage N; Martin JL; McManus ME
    Int J Biochem Cell Biol; 2007; 39(4):685-9. PubMed ID: 17110154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. para-Nitrophenyl sulfate activation of human sulfotransferase 1A1 is consistent with intercepting the E[middle dot]PAP complex and reformation of E[middle dot]PAPS.
    Tyapochkin E; Cook PF; Chen G
    J Biol Chem; 2009 Oct; 284(43):29357-64. PubMed ID: 19706609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.